Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Study Objective :
To assess the efficacy and the safety of the combination of Oxaliplatin, and Vinorelbine with
or without Trastuzumab as a salvage regimen in patients with Metastatic Breast Cancer